You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Mental health, behavioural and neurodevelopmental conditions
  5. Drug misuse

Naltrexone for the management of opioid dependence

  • Technology appraisal guidance
  • Reference number: TA115
  • Published:  24 January 2007
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Consultee and commentator comments on the appraisal consultation document

  • Drug misuse - naltrexone, consultee and commentator comments: Welsh Assembly Government

  • Drug misuse - naltrexone, consultee and commentator comments: Specialist Clinical Addiction Network

  • Drug misuse - naltrexone, consultee and commentator comments: Royal College of Psychiatrists

  • Drug misuse - naltrexone, consultee and commentator comments: Royal College of Nursing

  • Drug misuse - naltrexone, consultee and commentator comments: NHS Quality Improvement Scotland

  • Drug misuse - naltrexone, consultee and commentator comments: Department of Health, Social Service and Public Safety (revised)

  • Drug misuse - naltrexone, consultee and commentator comments: Department of Health, Social Service and Public Safety

  • Drug misuse - naltrexone, consultee and commentator comments: British Association for Psychopharmacology


This page was last updated: 30 March 2010

Back to top